HTHenri Tuomilehto

Henri Tuomilehto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Henri Tuomilehto has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 January 2012
      • Vol. 128  (2) , 205-11

    [Surgery for lower nasolacrimal duct obstructions in adults].

    by Juha Seppä, Grigori Smirnov, Kai Kaarniranta, Henri Tuomilehto

    Epiphora and purulent discharge are common and irritating clinical manifestations of nasolacrimal duct obstruction (NLDO). If conservative treatment fails, dacryocystorhinostomy (DCR) has proven an efficient surgical method. The aim of DCR is to bypass the obstruction by creating a stoma between the lacrimal sac and the nasal cavity. External DCR has been the gold standard for decades. In recent years with the development of nasal endoscopes, less invasive surgical techniques, such as endonasal endoscopic DCR have become an increasingly popular procedure in the treatment of patients with NLDO. In such patients, the success rates for both external and endonasal DCR are about 90% and a successful procedure has a significant impact on the quality of life.

  • Initial improvements in apnoea-hypopnoea index after very low calorie diet maintained for 1 year with weight loss maintenance program

    by Henri P I Tuomilehto

    Obesity is the most important risk factor for obstructive sleep apnoea (OSA). The lack of well-designed studies on the effects of weight reduction on OSA has led to conclusions that although weight loss may reduce the severity of OSA, the beneficial effects may not be sustained and it is not curative. However, recent reports in patients with mild OSA and in OSA patients with type 2 diabetes raise questions about these conclusions.1 2 We also need well-controlled trials on the effects of weight reduction programs among patients with more severe OSA. The aim of the study was to determine whether initial improvements in OSA after a …


  • Reply to E Hemmingsson et al

    by Henri Tuomilehto, Juha Seppä, Markku Peltonen

  • Effect of weight loss on inflammation in patients with mild obstructive sleep apnea

    by J. Sahlman, J. Seppä, C. Herder, M. Peltonen, K. Peuhkurinen, H. Gylling, E. Vanninen, H. Tukiainen, K. Punnonen, M. Partinen, et al.


  • Open Access

    Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity–based lifestyle intervention: postinterventional follow-up

    by Henri Tuomilehto, Helena Gylling, Markku Peltonen, Tarja Martikainen, Johanna Sahlman, Jouko Kokkarinen, Jukka Randell, Hannu Tukiainen, Esko Vanninen, Markku Partinen, et al.

    Background: Obesity is the most important risk factor for obstructive sleep apnea (OSA). Weight-reduction programs have been observed to represent ef


  • Open Access

    The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea

    by Johanna Sahlman, Kati Miettinen, Keijo Peuhkurinen, Juha Seppä, Markku Peltonen, Christian Herder, Kari Punnonen, Esko Vanninen, Helena Gylling, Markku Partinen, et al.

    It is widely accepted that obstructive sleep apnoea (OSA) is linked with cardiovascular diseases. The relationship is complex and remains still poorly understood. The presence of chronic systemic inflammation has been connected with pathogenesis of both OSA and cardiovascular diseases. While atherogenesis is believed to be a process of many years, little is known about the potential impact of the largest OSA subgroup, mild OSA, on the development of cardiovascular diseases. The aim of the present study was to assess whether untreated mild OSA is associated with an activation of inflammatory cytokine system. The adult study population consisted of two groups: 84 patients with mild OSA [apnoea–hypopnoea index (AHI) 5–15 h−1] and 40 controls (AHI −1). Serum concentrations of pro‐ and anti‐inflammatory cytokines were measured before any interventions. After adjustments for age, sex, body mass index, fat percentage, most important cardiometabolic and inflammatory diseases, and non‐steroidal anti‐inflammatory medication, the mean level of tumour necrosis factor‐α was significantly elevated (1.54 versus 1.17 pg mL−1, P = 0.004), whereas the level of interleukin‐1β (IL‐1β) was reduced (0.19 versus 0.23 pg mL−1, P = 0.004) in patients with mild OSA compared with controls. The concentrations of the protective anti‐inflammatory cytokines, interleukin‐10 (1.28 versus 0.70 pg mL−1, P < 0.001) and interleukin‐1 receptor antagonist (478 versus 330 pg mL−1, P = 0.003) were elevated in the OSA group. The concentrations of C‐reactive protein increased, but IL‐1β decreased along with the increase of AHI. Mild OSA was found to be associated not only with the activation of the pro‐inflammatory, but also with the anti‐inflammatory systems.


  • Open Access

    Sleep Duration, Lifestyle Intervention, and Incidence of Type 2 Diabetes in Impaired Glucose Tolerance

    by Henri Tuomilehto, Markku Peltonen, Markku Partinen, Gilles Lavigne, Johan G. Eriksson, Christian Herder, Sirkka Aunola, Sirkka Keinänen-Kiukaanniemi, Pirjo Ilanne-Parikka, Matti Uusitupa, et al.

    OBJECTIVE Both short and long sleep duration have frequently been found to be associated with an increased risk for diabetes. The aim of the present exploratory analysis was to examine the association between sleep duration and type 2 diabetes after lifestyle intervention in overweight individuals with impaired glucose tolerance in a 7-year prospective follow-up. RESEARCH DESIGN AND METHODS A total of 522 individuals (aged 40–64 years) were randomly allocated either to an intensive diet-exercise counseling group or to a control group. Diabetes incidence during follow-up was calculated according to sleep duration at baseline. Sleep duration was obtained for a 24-h period. Physical activity, dietary intakes, body weight, and immune mediators (C-reactive protein and interleukin-6) were measured. RESULTS Interaction between sleep duration and treatment group was statistically significant (P = 0.003). In the control group, the adjusted hazard ratios (HRs) (95% CI) for diabetes were 2.29 (1.38–3.80) and 2.74 (1.67–4.50) in the sleep duration groups 9–9.5 h and ≥10 h, respectively, compared with for that of the 7–8.5 h group. In contrast, sleep duration did not influence the incidence of diabetes in the intervention group; for sleep duration groups 9–9.5 h and ≥10 h, the adjusted HRs (95% CI) were 1.10 (0.60–2.01) and 0.73 (0.34–1.56), respectively, compared with that in the reference group (7–8.5 h sleep). Lifestyle intervention resulted in similar improvement in body weight, insulin sensitivity, and immune mediator levels regardless of sleep duration. CONCLUSIONS Long sleep duration is associated with increased type 2 diabetes risk. Lifestyle intervention with the aim of weight reduction, healthy diet, and increased physical activity may ameliorate some of this excess risk.


  • Lifestyle Intervention with Weight Reduction: First-line Treatment in Mild Obstructive Sleep Apnea

    by Henri P. I. Tuomilehto, Juha M. Seppä, Markku M. Partinen, Markku Peltonen, Helena Gylling, Jaakko O. I. Tuomilehto, Esko J. Vanninen, Jouko Kokkarinen, Johanna K. Sahlman, Tarja Martikainen, et al.

    Rationale: Obesity is the most important risk factor for obstructive sleep apnea (OSA). However, although included in clinical guidelines, no randomized controlled studies have been performed on the effects of weight reduction on mild OSA. Objectives: The aim of this prospective, randomized controlled parallel-group 1-year follow-up study was to determine whether a very low calorie diet (VLCD) with supervised lifestyle counseling could be an effective treatment for adults with mild OSA. Methods: Seventy-two consecutive overweight patients (body mass index, 28–40) with mild OSA were recruited. The intervention group (n = 35) completed the VLCD program with supervised lifestyle modification, and the control group (n = 37) received routine lifestyle counseling. The apnea–hypopnea index (AHI) was the main objectively measured outcome variable. Change in symptoms and the 15D-Quality of Life tool were used as subjective measurements. Measurements and Main Results: The lifestyle intervention was found to effectively reduce body weight (−10.7 ± 6.5 kg; body mass index, −3.5 ± 2.1 [mean ± SD]). There was a statistically significant difference in the mean change in AHI between the study groups (P = 0.017). The adjusted odds ratio for having mild OSA was markedly lowered (odds ratio, 0.24 [95% confidence interval, 0.08–0.72]; P = 0.011) in the intervention group. All common symptoms related to OSA, and some features of 15D-Quality of Life improved after the lifestyle intervention. Changes in AHI were strongly associated with changes in weight and waist circumference. Conclusions: VLCD combined with active lifestyle counseling resulting in marked weight reduction is a feasible and effective treatment for the majority of patients with mild OSA, and the achieved beneficial outcomes are maintained at 1-year follow-up.


    • 1 September 2008
      • Vol. 46  (3) , 238-42

    Repeated early debridement does not provide significant symptomatic benefit after ESS.

    by Tatu Kemppainen, Juha Seppä, Henri Tuomilehto, Hannu Kokki, Juhani Nuutinen

    Postoperative debridement is considered essential after endoscopic sinus surgery (ESS), however, its effect on postoperative symptoms is largely unexplored. In the present study 90 patients undergoing ESS were randomized to debridement of the nasal cavities either three times during the first postoperative week (intervention group), or once on the 7th postoperative day (control group). Postoperative saline douching was used in both groups. The primary outcome measure was the postoperative Lund-MacKay Symptom Score. The patients in the intervention group reported less severe symptoms on all domains of the Lund-MacKay Score compared with the patients in the control group both at one and four weeks. The difference between the groups was statistically significant in discharge at one week (4.1 +/- 2.3 in the intervention group and 5.4 +/- 2.6 in the control group, p = 0.0025). At four weeks, significantly fewer nasal cavities presented with nasal secretions in the intervention group compared with the control group (14/84 vs. 38/93). Repeated debridement during the first postoperative week produced minor symptomatic benefit in patients recovering from ESS. Therefore, in terms of subjective recovery and health care costs repeated debridement is not justified during the first postoperative week after ESS.


  • Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women – The FIN-D2D survey

    by Henri Tuomilehto, Markku Peltonen, Markku Partinen, Juha Seppä, Timo Saaristo, Eeva Korpi-Hyövälti, Heikki Oksa, Hannu Puolijoki, Juha Saltevo, Mauno Vanhala, et al.